A Systems Vaccinology Approach Reveals the Mechanisms of Immunogenic Responses to Hantavax Vaccination in Humans

Adnan Khan, Ok Sarah Shin, Jinhyuk Na, Jae Kwan Kim, Rak Kyun Seong, Man Seong Park, Ji Yun Noh, Joon Young Song, Hee Jin Cheong, Youngja Hwang Park, Woo Joo Kim

Research output: Contribution to journalArticlepeer-review

24 Citations (Scopus)


Hantavax is an inactivated vaccine for hemorrhagic fever with renal syndrome (HFRS). The immunogenic responses have not been elucidated yet. Here we conducted a cohort study in which 20 healthy subjects were administered four doses of Hantavax during 13-months period. Pre- and post- vaccinated peripheral blood mononuclear cells (PBMCs) and sera were analysed by transcriptomic and metabolomic profilings, respectively. Based on neutralizing antibody titers, subjects were subsequently classified into three groups; non responders (NRs), low responders (LRs) and high responders (HRs). Post vaccination differentially expressed genes (DEGs) associated with innate immunity and cytokine pathways were highly upregulated. DEG analysis revealed a significant induction of CD69 expression in the HRs. High resolution metabolomics (HRM) analysis showed that correlated to the antibody response, cholesteryl nitrolinoleate, octanoyl-carnitine, tyrosine, ubiquinone-9, and benzoate were significantly elevated in HRs, while chenodeoxycholic acid and methyl palmitate were upregulated in NRs and LRs, compared with HRs. Additionally, gene-metabolite interaction revealed upregulated gene-metabolite couplings in, folate biosynthesis, nicotinate and nicotinamide, arachidonic acid, thiamine and pyrimidine metabolism in a dose dependent manner in HR group. Collectively, our data provide new insight into the underlying mechanisms of the Hantavax-mediated immunogenicity in humans.

Original languageEnglish
Article number4760
JournalScientific reports
Issue number1
Publication statusPublished - 2019 Dec 1

Bibliographical note

Funding Information:
We thank the participants, and study coordinators (Mi Suk Lee, Eun Mi Yu, Eun Jeong Kim) for their help in recruitment, vaccination and follow up of participants. This study was supported by grants from Green Cross Corporation, Yongin, Republic of Korea. The sponsor participated in the clinical trial design, execution, and the data collections. Although the sponsor reviewed the penultimate draft, the opinions expressed are those of the authorship and may not necessarily reflect those of the sponsor. This research was also supported by the Basic Science Research Program of the National Research Foundation of Korea (NRF-2017R1A2B4003890).

Publisher Copyright:
© 2019, The Author(s).

ASJC Scopus subject areas

  • General


Dive into the research topics of 'A Systems Vaccinology Approach Reveals the Mechanisms of Immunogenic Responses to Hantavax Vaccination in Humans'. Together they form a unique fingerprint.

Cite this